nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—SLC6A3—schizophrenia	0.472	0.572	CbGaD
Sibutramine—SLC6A4—schizophrenia	0.353	0.428	CbGaD
Sibutramine—SLC6A2—locus ceruleus—schizophrenia	0.0132	0.202	CbGeAlD
Sibutramine—SLC6A3—telencephalic ventricle—schizophrenia	0.00774	0.119	CbGeAlD
Sibutramine—SLC6A2—autonomic nervous system—schizophrenia	0.007	0.108	CbGeAlD
Sibutramine—SLC6A4—blood plasma—schizophrenia	0.00338	0.052	CbGeAlD
Sibutramine—CYP3A4—urine—schizophrenia	0.00317	0.0488	CbGeAlD
Sibutramine—SLC6A3—forebrain—schizophrenia	0.00202	0.0311	CbGeAlD
Sibutramine—SLC6A3—telencephalon—schizophrenia	0.00186	0.0286	CbGeAlD
Sibutramine—SLC6A4—forebrain—schizophrenia	0.00185	0.0285	CbGeAlD
Sibutramine—SLC6A4—telencephalon—schizophrenia	0.0017	0.0262	CbGeAlD
Sibutramine—CYP3A4—blood plasma—schizophrenia	0.00166	0.0255	CbGeAlD
Sibutramine—SLC6A2—forebrain—schizophrenia	0.00163	0.0251	CbGeAlD
Sibutramine—SLC6A2—telencephalon—schizophrenia	0.0015	0.0231	CbGeAlD
Sibutramine—SLC6A3—midbrain—schizophrenia	0.00133	0.0205	CbGeAlD
Sibutramine—SLC6A2—gonad—schizophrenia	0.00125	0.0192	CbGeAlD
Sibutramine—SLC6A4—blood—schizophrenia	0.00124	0.019	CbGeAlD
Sibutramine—SLC6A4—midbrain—schizophrenia	0.00122	0.0188	CbGeAlD
Sibutramine—SLC6A3—nervous system—schizophrenia	0.0011	0.0169	CbGeAlD
Sibutramine—SLC6A4—endocrine gland—schizophrenia	0.00107	0.0165	CbGeAlD
Sibutramine—SLC6A3—central nervous system—schizophrenia	0.00106	0.0162	CbGeAlD
Sibutramine—SLC6A3—cerebellum—schizophrenia	0.00103	0.0159	CbGeAlD
Sibutramine—SLC6A4—nervous system—schizophrenia	0.00101	0.0155	CbGeAlD
Sibutramine—SLC6A4—central nervous system—schizophrenia	0.000968	0.0149	CbGeAlD
Sibutramine—SLC6A2—endocrine gland—schizophrenia	0.000946	0.0145	CbGeAlD
Sibutramine—SLC6A2—nervous system—schizophrenia	0.000885	0.0136	CbGeAlD
Sibutramine—SLC6A2—central nervous system—schizophrenia	0.000852	0.0131	CbGeAlD
Sibutramine—SLC6A3—brain—schizophrenia	0.000839	0.0129	CbGeAlD
Sibutramine—SLC6A4—brain—schizophrenia	0.000768	0.0118	CbGeAlD
Sibutramine—SLC6A2—brain—schizophrenia	0.000677	0.0104	CbGeAlD
Sibutramine—SLC6A4—Synaptic Vesicle Pathway—SNAP25—schizophrenia	0.000627	0.00573	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—NOS1—schizophrenia	0.000618	0.00565	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—TH—schizophrenia	0.000618	0.00565	CbGpPWpGaD
Sibutramine—CYP3A4—blood—schizophrenia	0.000607	0.00933	CbGeAlD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—HTR3A—schizophrenia	0.000559	0.00511	CbGpPWpGaD
Sibutramine—SLC6A3—Parkinsons Disease Pathway—TH—schizophrenia	0.000539	0.00493	CbGpPWpGaD
Sibutramine—CYP3A4—endocrine gland—schizophrenia	0.000526	0.00809	CbGeAlD
Sibutramine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—schizophrenia	0.000497	0.00454	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—PICK1—schizophrenia	0.000495	0.00453	CbGpPWpGaD
Sibutramine—CYP3A4—nervous system—schizophrenia	0.000492	0.00757	CbGeAlD
Sibutramine—CYP3A4—central nervous system—schizophrenia	0.000474	0.00729	CbGeAlD
Sibutramine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—schizophrenia	0.00046	0.0042	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—GCLM—schizophrenia	0.000446	0.00408	CbGpPWpGaD
Sibutramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—schizophrenia	0.000438	0.00401	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—TPH1—schizophrenia	0.000423	0.00387	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CHRNA7—schizophrenia	0.000423	0.00387	CbGpPWpGaD
Sibutramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—schizophrenia	0.000404	0.00369	CbGpPWpGaD
Sibutramine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—schizophrenia	0.000388	0.00355	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GCLM—schizophrenia	0.000384	0.00351	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—PICK1—schizophrenia	0.000379	0.00347	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—SYN2—schizophrenia	0.000375	0.00343	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—RIMS1—schizophrenia	0.000375	0.00343	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—SYN3—schizophrenia	0.000375	0.00343	CbGpPWpGaD
Sibutramine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—schizophrenia	0.00037	0.00338	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GRIN2D—schizophrenia	0.000361	0.0033	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GRIN2C—schizophrenia	0.000361	0.0033	CbGpPWpGaD
Sibutramine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—schizophrenia	0.000357	0.00327	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—KCNN3—schizophrenia	0.000353	0.00322	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—HCN1—schizophrenia	0.000353	0.00322	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—KCNV1—schizophrenia	0.000353	0.00322	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—GRIN1—schizophrenia	0.000352	0.00322	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GRIK3—schizophrenia	0.000349	0.00319	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—TPH1—schizophrenia	0.000346	0.00316	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GCLM—schizophrenia	0.00034	0.00311	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—SLC6A1—schizophrenia	0.000338	0.00309	CbGpPWpGaD
Sibutramine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—schizophrenia	0.000335	0.00306	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—GAPDH—schizophrenia	0.000332	0.00304	CbGpPWpGaD
Sibutramine—SLC6A4—Monoamine Transport—IL1B—schizophrenia	0.000331	0.00303	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—TPH2—schizophrenia	0.000321	0.00293	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—CHRM1—schizophrenia	0.000316	0.00289	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—SLC1A1—schizophrenia	0.000311	0.00284	CbGpPWpGaD
Sibutramine—CYP3A4—Xenobiotics—CYP2D6—schizophrenia	0.00031	0.00283	CbGpPWpGaD
Sibutramine—CYP3A4—Estrogen metabolism—CYP1A2—schizophrenia	0.000305	0.00278	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CHRNB2—schizophrenia	0.000304	0.00278	CbGpPWpGaD
Sibutramine—CYP3A4—Tamoxifen metabolism—CYP2D6—schizophrenia	0.000298	0.00272	CbGpPWpGaD
Sibutramine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—schizophrenia	0.000292	0.00267	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—SLC6A1—schizophrenia	0.000291	0.00266	CbGpPWpGaD
Sibutramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—schizophrenia	0.000288	0.00263	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—RIMS1—schizophrenia	0.000288	0.00263	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—SYN2—schizophrenia	0.000288	0.00263	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—SYN3—schizophrenia	0.000288	0.00263	CbGpPWpGaD
Sibutramine—SLC6A2—Monoamine Transport—IL1B—schizophrenia	0.000285	0.0026	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC1A1—schizophrenia	0.000285	0.0026	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—SLC17A7—schizophrenia	0.000284	0.0026	CbGpPWpGaD
Sibutramine—CYP3A4—Xenobiotics—CYP1A2—schizophrenia	0.00028	0.00256	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GRIN2D—schizophrenia	0.000277	0.00253	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GRIN2C—schizophrenia	0.000277	0.00253	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—schizophrenia	0.000276	0.00252	CbGpPWpGaD
Sibutramine—CYP3A4—Tamoxifen metabolism—CYP1A2—schizophrenia	0.000269	0.00246	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—CLOCK—schizophrenia	0.000269	0.00246	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GRIK3—schizophrenia	0.000267	0.00244	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—HTR1A—schizophrenia	0.000266	0.00243	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—CHRNA7—schizophrenia	0.000264	0.00242	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GRIK1—schizophrenia	0.000264	0.00242	CbGpPWpGaD
Sibutramine—CYP3A4—Tryptophan metabolism—TPH1—schizophrenia	0.000262	0.0024	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—TPH2—schizophrenia	0.000262	0.00239	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC17A7—schizophrenia	0.00026	0.00238	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—SLC6A1—schizophrenia	0.000258	0.00236	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—SNAP25—schizophrenia	0.000257	0.00234	CbGpPWpGaD
Sibutramine—CYP3A4—Estrogen metabolism—COMT—schizophrenia	0.000255	0.00233	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—IL1B—schizophrenia	0.000252	0.00231	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GABRB2—schizophrenia	0.000252	0.00231	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC1A1—schizophrenia	0.000252	0.0023	CbGpPWpGaD
Sibutramine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—schizophrenia	0.000252	0.0023	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—ADORA2A—schizophrenia	0.00025	0.00228	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—NTRK2—schizophrenia	0.00025	0.00228	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GAD2—schizophrenia	0.000249	0.00227	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—CHRNB2—schizophrenia	0.000248	0.00227	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—HSPA1A—schizophrenia	0.000243	0.00222	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—NEFL—schizophrenia	0.000242	0.00221	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—SLC6A3—schizophrenia	0.000241	0.0022	CbGpPWpGaD
Sibutramine—SLC6A4—Monoamine Transport—TNF—schizophrenia	0.00024	0.0022	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—SLC1A1—schizophrenia	0.000238	0.00218	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26B1—schizophrenia	0.000238	0.00218	CbGpPWpGaD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP26B1—schizophrenia	0.000235	0.00215	CbGpPWpGaD
Sibutramine—CYP3A4—Estrogen metabolism—GSTM1—schizophrenia	0.000233	0.00213	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—SLC6A4—schizophrenia	0.000233	0.00213	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC17A7—schizophrenia	0.000231	0.00211	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—TH—schizophrenia	0.000229	0.00209	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GRIK2—schizophrenia	0.000225	0.00205	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GRIN1—schizophrenia	0.00022	0.00201	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—SLC17A7—schizophrenia	0.000218	0.00199	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—SLC18A2—schizophrenia	0.000218	0.00199	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GAD1—schizophrenia	0.000216	0.00197	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—CHRNA3—schizophrenia	0.000216	0.00197	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—FXYD6—schizophrenia	0.000214	0.00196	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—NPS—schizophrenia	0.000214	0.00195	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—DRD1—schizophrenia	0.000209	0.00191	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—HSPA1A—schizophrenia	0.000209	0.00191	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—SLC6A3—schizophrenia	0.000207	0.00189	CbGpPWpGaD
Sibutramine—SLC6A2—Monoamine Transport—TNF—schizophrenia	0.000207	0.00189	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—SLC6A4—schizophrenia	0.000206	0.00188	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—GSTP1—schizophrenia	0.000204	0.00186	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—DRD3—schizophrenia	0.000203	0.00185	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—CHRNA7—schizophrenia	0.000203	0.00185	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GRIK1—schizophrenia	0.000203	0.00185	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GRIA1—schizophrenia	0.0002	0.00183	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GRIN2A—schizophrenia	0.0002	0.00183	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—SLC6A1—schizophrenia	0.0002	0.00183	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—CAMK2B—schizophrenia	0.0002	0.00183	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—CACNB2—schizophrenia	0.0002	0.00183	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC18A2—schizophrenia	0.000199	0.00182	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—DRD4—schizophrenia	0.000197	0.0018	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GABRB2—schizophrenia	0.000193	0.00177	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—MAOA—schizophrenia	0.000193	0.00176	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP26B1—schizophrenia	0.000193	0.00176	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GAD2—schizophrenia	0.00019	0.00174	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—CHRNB2—schizophrenia	0.00019	0.00173	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—FXYD6—schizophrenia	0.00019	0.00173	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—GSTM1—schizophrenia	0.000187	0.00171	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—TH—schizophrenia	0.000187	0.00171	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—BDNF—schizophrenia	0.000186	0.0017	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—NEFL—schizophrenia	0.000185	0.00169	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—HSPA1A—schizophrenia	0.000185	0.00169	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—NRG1—schizophrenia	0.000184	0.00168	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—DRD2—schizophrenia	0.000183	0.00168	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—HTR7—schizophrenia	0.000183	0.00168	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—schizophrenia	0.000183	0.00168	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—schizophrenia	0.000183	0.00167	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—TNF—schizophrenia	0.000183	0.00167	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL10—schizophrenia	0.000178	0.00162	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC18A2—schizophrenia	0.000176	0.00161	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GSTP1—schizophrenia	0.000175	0.0016	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—MEF2C—schizophrenia	0.000173	0.00158	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—CHRNA4—schizophrenia	0.000172	0.00157	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GRIK2—schizophrenia	0.000172	0.00157	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GRIN1—schizophrenia	0.000169	0.00154	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—YWHAZ—schizophrenia	0.000167	0.00153	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—SLC18A2—schizophrenia	0.000167	0.00152	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—CHRNA3—schizophrenia	0.000165	0.00151	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GAD1—schizophrenia	0.000165	0.00151	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—schizophrenia	0.000162	0.00148	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—HTR3A—schizophrenia	0.000162	0.00148	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GSTM1—schizophrenia	0.000161	0.00147	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—SNAP25—schizophrenia	0.00016	0.00146	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—NRG1—schizophrenia	0.000158	0.00145	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—HSPA8—schizophrenia	0.000158	0.00144	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—schizophrenia	0.000157	0.00144	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GSTP1—schizophrenia	0.000155	0.00142	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GRIN2A—schizophrenia	0.000154	0.0014	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—CACNB2—schizophrenia	0.000154	0.0014	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—SLC6A1—schizophrenia	0.000154	0.0014	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GRIA1—schizophrenia	0.000154	0.0014	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—CAMK2B—schizophrenia	0.000154	0.0014	CbGpPWpGaD
Sibutramine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—schizophrenia	0.000152	0.00139	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—DLG4—schizophrenia	0.000148	0.00135	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—NDST3—schizophrenia	0.000147	0.00135	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—CHRNB2—schizophrenia	0.000145	0.00133	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GRIN2B—schizophrenia	0.000145	0.00132	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC1A1—schizophrenia	0.000145	0.00132	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—schizophrenia	0.000145	0.00132	CbGpPWpGaD
Sibutramine—CYP3A4—Tryptophan metabolism—CYP1A2—schizophrenia	0.000144	0.00131	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—HTR3A—schizophrenia	0.000144	0.00131	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GSTM1—schizophrenia	0.000143	0.00131	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—NRG1—schizophrenia	0.00014	0.00128	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC17A7—schizophrenia	0.000132	0.00121	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—CHRNA4—schizophrenia	0.000132	0.00121	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—schizophrenia	0.000131	0.00119	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—schizophrenia	0.000129	0.00117	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC1A1—schizophrenia	0.000128	0.00117	CbGpPWpGaD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—schizophrenia	0.000127	0.00116	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—SNAP25—schizophrenia	0.000123	0.00112	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—COMT—schizophrenia	0.000121	0.00111	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—HSPA8—schizophrenia	0.000121	0.00111	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—MAOA—schizophrenia	0.000121	0.0011	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—GABRB2—schizophrenia	0.000117	0.00107	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC17A7—schizophrenia	0.000117	0.00107	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—schizophrenia	0.000116	0.00106	CbGpPWpGaD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—schizophrenia	0.000115	0.00105	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—DLG4—schizophrenia	0.000114	0.00104	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GRIN2B—schizophrenia	0.000111	0.00101	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—schizophrenia	0.000104	0.000952	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—GABRB2—schizophrenia	0.000104	0.00095	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—GSK3B—schizophrenia	0.000103	0.000945	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—CYP26B1—schizophrenia	0.000102	0.000937	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC18A2—schizophrenia	0.000101	0.000925	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP26B1—schizophrenia	0.000101	0.000924	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—schizophrenia	9.42e-05	0.000861	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL1B—schizophrenia	9.33e-05	0.000852	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC6A1—schizophrenia	9.32e-05	0.000852	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—COMT—schizophrenia	9.3e-05	0.00085	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—MAOA—schizophrenia	9.24e-05	0.000844	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GCLM—schizophrenia	9.14e-05	0.000835	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC18A2—schizophrenia	8.97e-05	0.00082	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—EP300—schizophrenia	8.34e-05	0.000762	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ATP2A2—schizophrenia	8.3e-05	0.000759	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC6A1—schizophrenia	8.25e-05	0.000754	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	7.84e-05	0.000717	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ATP2A2—schizophrenia	7.36e-05	0.000672	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—EP300—schizophrenia	6.81e-05	0.000622	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—TNF—schizophrenia	6.77e-05	0.000618	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—schizophrenia	6.64e-05	0.000607	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—CYP2D6—schizophrenia	5.53e-05	0.000506	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP2D6—schizophrenia	5.46e-05	0.000499	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ABCB1—schizophrenia	5.32e-05	0.000486	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—CYP1A2—schizophrenia	5.01e-05	0.000457	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP1A2—schizophrenia	4.94e-05	0.000451	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—TP53—schizophrenia	4.87e-05	0.000445	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ABCB1—schizophrenia	4.71e-05	0.000431	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—APOA1—schizophrenia	4.2e-05	0.000384	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—COMT—schizophrenia	4.19e-05	0.000383	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTP1—schizophrenia	4.17e-05	0.000382	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—MAOA—schizophrenia	4.16e-05	0.000381	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—COMT—schizophrenia	4.14e-05	0.000378	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTP1—schizophrenia	4.12e-05	0.000376	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTM1—schizophrenia	3.84e-05	0.000351	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTM1—schizophrenia	3.78e-05	0.000346	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—APOA1—schizophrenia	3.72e-05	0.00034	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PRODH—schizophrenia	3.59e-05	0.000328	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—MPC2—schizophrenia	2.93e-05	0.000267	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PLCH2—schizophrenia	2.72e-05	0.000249	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NDST3—schizophrenia	2.56e-05	0.000234	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SLC27A5—schizophrenia	2.42e-05	0.000222	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ACSL6—schizophrenia	2.42e-05	0.000222	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—DAO—schizophrenia	2.31e-05	0.000211	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PNP—schizophrenia	2.22e-05	0.000203	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NDUFV2—schizophrenia	2.06e-05	0.000188	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIP4K2A—schizophrenia	1.94e-05	0.000177	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP26B1—schizophrenia	1.75e-05	0.00016	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—TPH1—schizophrenia	1.56e-05	0.000143	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GCLM—schizophrenia	1.56e-05	0.000143	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PRKD1—schizophrenia	1.47e-05	0.000134	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GAPDH—schizophrenia	1.23e-05	0.000112	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CLOCK—schizophrenia	1.21e-05	0.000111	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—TPH2—schizophrenia	1.18e-05	0.000108	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CACNB2—schizophrenia	1.18e-05	0.000108	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—DPYD—schizophrenia	1.16e-05	0.000106	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CACNA1C—schizophrenia	1.08e-05	9.9e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3C2A—schizophrenia	1.06e-05	9.64e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP2D6—schizophrenia	9.46e-06	8.65e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SNAP25—schizophrenia	9.46e-06	8.65e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP1A2—schizophrenia	8.56e-06	7.82e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—TH—schizophrenia	8.44e-06	7.71e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—COMT—schizophrenia	7.17e-06	6.56e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTP1—schizophrenia	7.14e-06	6.52e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—MAOA—schizophrenia	7.12e-06	6.51e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ABCB1—schizophrenia	6.76e-06	6.18e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PLA2G4A—schizophrenia	6.56e-06	6e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTM1—schizophrenia	6.56e-06	6e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—MTHFR—schizophrenia	5.8e-06	5.3e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APOE—schizophrenia	5.4e-06	4.93e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APOA1—schizophrenia	5.34e-06	4.88e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—EP300—schizophrenia	3.08e-06	2.81e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—AKT1—schizophrenia	1.86e-06	1.7e-05	CbGpPWpGaD
